Trial · NCT01668667
Adverse events40
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 40
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Somnolence | Nervous system disorders | GSK1838262 600 mg | 13 | 122 | |
| other | Somnolence | Nervous system disorders | GSK1838262 450 mg | 20 | 123 | |
| other | Somnolence | Nervous system disorders | GSK1838262 300 mg | 12 | 121 | |
| other | Somnolence | Nervous system disorders | GSK1838262 Placebo Match | 8 | 121 | |
| other | Headache | Nervous system disorders | GSK1838262 600 mg | 11 | 122 | |
| other | Headache | Nervous system disorders | GSK1838262 450 mg | 9 | 123 | |
| other | Headache | Nervous system disorders | GSK1838262 300 mg | 10 | 121 | |
| other | Headache | Nervous system disorders | GSK1838262 Placebo Match | 12 | 121 | |
| other | Dizziness | Nervous system disorders | GSK1838262 600 mg | 15 | 122 | |
| other | Dizziness | Nervous system disorders | GSK1838262 450 mg | 8 | 123 | |
| other | Dizziness | Nervous system disorders | GSK1838262 300 mg | 5 | 121 | |
| other | Dizziness | Nervous system disorders | GSK1838262 Placebo Match | 5 | 121 | |
| other | Upper respiratory tract infection | Respiratory, thoracic and mediastinal disorders | GSK1838262 600 mg | 6 | 122 | |
| other | Upper respiratory tract infection | Respiratory, thoracic and mediastinal disorders | GSK1838262 450 mg | 10 | 123 | |
| other | Upper respiratory tract infection | Respiratory, thoracic and mediastinal disorders | GSK1838262 300 mg | 3 | 121 | |
| other | Upper respiratory tract infection | Respiratory, thoracic and mediastinal disorders | GSK1838262 Placebo Match | 7 | 121 | |
| other | Nausea | Gastrointestinal disorders | GSK1838262 600 mg | 5 | 122 | |
| other | Nausea | Gastrointestinal disorders | GSK1838262 450 mg | 4 | 123 | |
| other | Nausea | Gastrointestinal disorders | GSK1838262 300 mg | 3 | 121 | |
| other | Nausea | Gastrointestinal disorders | GSK1838262 Placebo Match | 7 | 121 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01668667/events